USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CYTOSORBENTS, INC.
Address:
7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION, NJ 99999-
Phone:
N/A
URL:
EIN:
120449640
DUNS:
830014077
Number of Employees:
15
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $353,351.00 2
SBIR Phase II $1,000,000.00 1

Award List:

Investigation of CytoSorb cytokine and myoglobin removal in the treatment of trauma

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$150,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Phillip Chan, President – (732) 329-8885
Abstract:
Polytrauma is the leading cause of military casualties and is a potent trigger of the immune response. Tissue damage, infection, burns, hemorrhage, ischemia and reperfusion, and cell necrosis triggers the immune system to produce excessive levels of cytokines, often called cytokine storm, that can… More

Investigation of CytoSorb cytokine and myoglobin removal in the treatment of trauma and burn injury

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,000,000.00
Agency:
DOD
Principal Investigator:
Phillip Chan, CEO – (732) 329-8885
Abstract:
Trauma and burn injuries are leading causes of military casualties and need more effective treatments. They are frequently associated with a severe systemic inflammatory response syndrome, triggered by tissue damage, cytokine and inflammatory mediator release, ischemia-reperfusion injury, and… More

SBIR Topic 74, Phase I, pRBC Contaminant Removal with Porous Polymer Beads

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$203,351.00
Agency:
HHS
Principal Investigator:
Phillip Chan – 732-329-8885
Abstract:
Not Available